INSIDER · CIK 2026090
Korczynski Sherry
Chief Commercial Officer at Aquestive Therapeutics, Inc. (AQST)
↗3 Form 4 rows in the window
Covers original filings from Aug 1, 2026 to Oct 29, 2026. Older trades and amendments are in the SEC history.
$0.00Bought on the market
$46KSold on the market
1Companies
Sep 11, 2026Latest filing
| Company | Title | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 11, 202611:07 | Sep 9, 2026 | AQSTAquestive Therapeutics, Inc. | Chief Commercial Officer | S · Sell10b5-1 | $5.22 | −8,750 | 235,689 | -4% | −$46K | ||
| Sep 11, 202611:07 | Sep 9, 2026 | AQSTAquestive Therapeutics, Inc. | Chief Commercial Officer | M · Exercise10b5-1 | $2.65 | +8,750 | 244,439 | +4% | $23K | ||
| Aug 17, 202617:33 | Aug 14, 2026 | AQSTAquestive Therapeutics, Inc. | Chief Commercial Officer | F · Tax | $4.25 | −2,714 | 235,689 | -1% | $12K |